SEARCH RESULTS FOR:
Maggie Gómez Rábago
GENERAL DIRECTOR, CHARLOTTE CHEMICAL
Charlotte Chemical sets forth its expansion plans.
Federico De Simone
DIRECTOR, DE SIMONE GROUP
De Simone undertakes engineering and construction for the mining sector across West Africa.
Paul Nai
MANAGING DIRECTOR, LUBRIZOL SOUTHEAST ASIA
Lubrizol South East Asia comments on the rapidly expanding prospects in Southeast Asia.
Bernard Kaninda
AFRICA REGIONAL DIRECTOR, MAXAM
Maxam offers sophisticated blasting technology that considers all aspects of the conditions, as well as the environment that surrounds them in West Africa.
Kerry Knoll
EXECUTIVE CHAIRMAN, GENERATION MINING
Mining in Ontario and Toronto's Global Reach 2020
Generation Mining is doing its feasibility study on its Marathon palladium project, expecting to complete permitting early 2022.
Andrew Kaip
MANAGING DIRECTOR – EQUITY RESEARCH, RED CLOUD SECURITIES
Red Cloud Securities discusses how investors’ attitude towards precious metals mining companies remains cautious despite the price increases.
Hicham Aziz
COUNTRY MANAGER, SENEGAL, SAUDEQUIP (JA DELMAS)
Saudequip is developing its Caterpillar dealership in parallel with Senegal’s fast-growing mining industry.
Douglas MacQuarrie & Bashir Ahmed
PRESIDENT AND CEO & VICE PRESIDENT PRODUCTION AND DEVELOPMENT, ASANTE GOLD
Asante Gold is benefiting from strong gold prices to bring its Kubi mine in Ghana to production.
Duncan Middlemiss
PRESIDENT & CEO, WESDOME GOLD MINES
Mining in Ontario and Toronto's Global Reach 2020
Wesdome Gold Mines is enjoying improving market conditions at its mines in Québec and Ontario.
Martin Toscano
MANAGING DIRECTOR, EVONIK INDUSTRIES (MEXICO)
Evonik Mexico benefits from the country’s increasingly export-based economy.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
